Back

Latham & Watkins Advises on Windward Bio’s IPO

Windward Bio Group AG (Windward) (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, has announced the pricing of its initial public offering of 10,294,117 common shares at a public offering price of US$17 per share. In addition, Windward has granted the underwriters a 30-day option to purchase up to an additional 1,544,117 common shares at the initial public offering price, less the underwriting discounts and commissions. The gross proceeds to Windward from the initial public offering and the concurrent private placement, without giving effect to the underwriters’ option to purchase additional shares and before deducting underwriting discounts and commissions and offering expenses, are expected to be US$225 million. All of the common shares are being offered by Windward.

Latham & Watkins LLP advised the underwriters in the transaction with a Capital Markets team led by New York partners Nathan Ajiashvili and Kaj Nielsen, with associates Jie Lin Nai, Elana Cates, and Renad AlQarni.*

LEGAL DESIRE NEWSLETTER

Where the legal industry reads first.

Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.

No spam. Unsubscribe anytime.

From Legal Desire

Is your firm the one being cited, or the one being skipped?

We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.

Lawyers and firms: get featured on Legal Desire

Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.

Get featuredSubmit a press release
See the full deal record on DealDatabase
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
Cynthia Lydia Marbaniang
Associate & Staff Writer